Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

1 treatments under study, led by Cadwell Rapid Rate Magnetic Stimulator

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

Trial Status

Terminated1
Completed1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Cadwell Rapid Rate Magnetic Stimulator1

Active Sponsors

  • National Institute of Neurological Disorders and Stroke (NINDS)2

Top Investigators

Related Conditions

  • Parkinsons Disease1
  • Dementia1
  • Dystonia1
  • Focal Dystonia1
  • Healthy1

Activity Timeline